A detailed history of Fil LTD transactions in Danaher Corp stock. As of the latest transaction made, Fil LTD holds 1,524,634 shares of DHR stock, worth $355 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
1,524,634
Previous 300,357 407.61%
Holding current value
$355 Million
Previous $75 Million 464.78%
% of portfolio
0.41%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$239.25 - $280.76 $293 Million - $344 Million
1,224,277 Added 407.61%
1,524,634 $424 Million
Q2 2024

Aug 13, 2024

SELL
$235.51 - $267.98 $35 Million - $39.8 Million
-148,701 Reduced 33.11%
300,357 $75 Million
Q1 2024

May 13, 2024

SELL
$224.58 - $256.19 $17 Million - $19.4 Million
-75,739 Reduced 14.43%
449,058 $112 Million
Q4 2023

Feb 13, 2024

SELL
$185.1 - $233.13 $101 Million - $128 Million
-547,472 Reduced 51.06%
524,797 $121 Million
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $29.4 Million - $33.6 Million
-126,350 Reduced 10.54%
1,072,269 $266 Million
Q2 2023

Aug 11, 2023

SELL
$224.99 - $256.14 $161,992 - $184,420
-720 Reduced 0.06%
1,198,619 $288 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $255,813 - $295,559
1,067 Added 0.09%
1,199,339 $302 Million
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $13.6 Million - $15.9 Million
-56,449 Reduced 4.5%
1,198,272 $318 Million
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $4.79 Million - $29.2 Million
19,397 Added 1.57%
1,254,721 $324 Million
Q2 2022

Aug 12, 2022

SELL
$237.11 - $299.66 $50.5 Million - $63.8 Million
-212,902 Reduced 14.7%
1,235,324 $313 Million
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $105 Million - $129 Million
407,888 Added 39.21%
1,448,226 $425 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $13.6 Million - $15.3 Million
46,500 Added 4.68%
1,040,338 $342 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $1.17 Million - $1.43 Million
-4,314 Reduced 0.43%
993,838 $303 Million
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $23.8 Million - $28.7 Million
105,773 Added 11.85%
998,152 $268 Million
Q1 2021

May 14, 2021

BUY
$212.38 - $245.9 $68.6 Million - $79.4 Million
322,978 Added 56.72%
892,379 $201 Million
Q4 2020

Feb 08, 2021

BUY
$212.5 - $245.46 $12.3 Million - $14.2 Million
57,809 Added 11.3%
569,401 $126 Million
Q3 2020

Nov 13, 2020

SELL
$177.16 - $215.33 $23.7 Million - $28.8 Million
-133,775 Reduced 20.73%
511,592 $110 Million
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $3.8 Million - $5.22 Million
-29,510 Reduced 4.37%
645,367 $114 Million
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $36.5 Million - $50.8 Million
-300,318 Reduced 30.8%
674,877 $93.4 Million
Q4 2019

Feb 07, 2020

SELL
$133.47 - $153.48 $26.4 Million - $30.3 Million
-197,596 Reduced 16.85%
975,195 $150 Million
Q3 2019

Nov 13, 2019

SELL
$135.4 - $146.47 $20.7 Million - $22.4 Million
-153,209 Reduced 11.55%
1,172,791 $169 Million
Q2 2019

Aug 13, 2019

SELL
$124.88 - $143.73 $17.4 Million - $20 Million
-139,239 Reduced 9.5%
1,326,000 $190 Million
Q1 2019

May 13, 2019

BUY
$97.62 - $132.29 $10.2 Million - $13.8 Million
104,664 Added 7.69%
1,465,239 $193 Million
Q4 2018

Feb 13, 2019

BUY
$94.85 - $109.54 $45.2 Million - $52.2 Million
476,671 Added 53.93%
1,360,575 $140 Million
Q3 2018

Nov 09, 2018

BUY
$98.13 - $108.9 $20 Million - $22.2 Million
203,972 Added 30.0%
883,904 $96 Million
Q2 2018

Aug 10, 2018

BUY
$96.1 - $103.24 $45 Million - $48.3 Million
467,901 Added 220.68%
679,932 $67.1 Million
Q1 2018

May 14, 2018

BUY
$92.16 - $103.8 $3.76 Million - $4.24 Million
40,849 Added 23.86%
212,031 $20.8 Million
Q4 2017

Feb 12, 2018

BUY
$85.26 - $94.62 $11.6 Million - $12.9 Million
136,140 Added 388.51%
171,182 $15.9 Million
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $2.78 Million - $3.1 Million
35,042
35,042 $3.01 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.